NS-49, an α1A-adrenoceptor agonist, selectively increases intraurethral pressure in dogs

作者: Norihisa Taniguchi , Kozo Hamada , Takashi Ogasawara , Yojiro Ukai , Yoshiaki Yoshikuni

DOI: 10.1016/S0014-2999(96)00766-2

关键词:

摘要: Abstract The effects of NS-49 (( R )-(−)-3′-(2-amino-1-hydroxyethyl)-4′-fluoromethane sulfonanilide hydrochloride), an α 1A -adrenoceptor-selective agonist, on intraurethral pressure and blood were investigated in anesthetized dogs. In addition, the contractile isolated dog urethra carotid artery compared with those non-selective 1 -adrenoceptor agonists. Intravenously (i.v.) administered at 0.3 μg/kg or more significantly increased a dose-dependent manner. Much higher doses needed to increase pressure. contrast, ST-1059 (1-(2′,5′-dimethoxyphenyl)-2-aminoethanol) (an active metabolite midodrine) 30 both was 11-fold selective for than ST-1059. NS-49, ST-1059, phenylephrine noradrenaline caused concentration-dependent contraction urethra. only slight even high concentrations, whereas reference drugs contractions efficacy. antagonists 5-methylurapidil WB-4101 also showed affinity -adrenoceptors inhibiting [ 3 H]prazosin binding. conclusion, -selective agonist selectively presure dogs, produced These results suggest that subtype is responsible regulation pressure, might be useful treatment stress incontinence little effect cardiovascular system.

参考文章(21)
A. Öbrink, G. Bunne, The effect of alpha-adrenergic stimulation in stress incontinence. Scandinavian Journal of Urology and Nephrology. ,vol. 12, pp. 205- 208 ,(1978) , 10.3109/00365597809179717
Anthony P.D.W. Ford, Timothy J. Williams, David R. Blue, David E. Clarke, α1-Adrenoceptor classification: sharpening Occam's razor Trends in Pharmacological Sciences. ,vol. 15, pp. 167- 170 ,(1994) , 10.1016/0165-6147(94)90136-8
Kazuki Kazvabe, Nobuo Moriyama, Shizuo Yamada, Norihisa Taniguchi, Rationale for the use of alpha-blockers in the treatment of benign prostatic hyperplasia (BPH). International Journal of Urology. ,vol. 1, pp. 203- 211 ,(1994) , 10.1111/J.1442-2042.1994.TB00036.X
MartinC. Michel, PaulA. Insel, COMPARISON OF CLONED AND PHARMACOLOGICALLY DEFINED RAT TISSUE ALPHA 1-ADRENOCEPTOR SUBTYPES Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 350, pp. 136- 142 ,(1994) , 10.1007/BF00241087
Kenji Obika, Katsushi Shibata, Kuniko Horie, Rudolf Foglar, Kiyoshi Kimura, Gozoh Tsujimoto, NS-49, a novel α1a-adrenoceptor-selective agonist characterization using recombinant human α1-adrenoceptors European Journal of Pharmacology. ,vol. 291, pp. 327- 334 ,(1995) , 10.1016/0922-4106(95)90073-X
Anton D. Michel, Dana N. Loury, Roger L. Whiting, Identification of a single α1‐adrenoceptor corresponding to the α1A‐subtype in rat submaxillary gland British Journal of Pharmacology. ,vol. 98, pp. 883- 889 ,(1989) , 10.1111/J.1476-5381.1989.TB14617.X
Robert R. Ruffolo, Jeffrey M. Stadel, J. Paul Hieble, α‐adrenoceptors: Recent developments Medicinal Research Reviews. ,vol. 14, pp. 229- 270 ,(1994) , 10.1002/MED.2610140204
Akihiko Hatano, Hitoshi Takahashi, Makoto Tamaki, Takeshi Komeyama, Takako Koizumi, Masayuki Takeda, Pharmacological evidence of distinct alpha 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery. British Journal of Pharmacology. ,vol. 113, pp. 723- 728 ,(1994) , 10.1111/J.1476-5381.1994.TB17053.X
Hitoshi Kontani, Mikiko Nakagawa, Takeshi Sakai, Effects of Adrenergic Agonists on an Experimental Urinary Incontinence Model in Anesthetized Rabbits Japanese Journal of Pharmacology. ,vol. 58, pp. 339- 346 ,(1992) , 10.1254/JJP.58.339